| ¿µ¹® | congenital rubella syndrome | ÇÑ±Û | ¼±ÃµÇ³ÁøÁõÈıº |
|---|---|---|---|
| ¼³¸í | ÀӽűⰣ Áß¿¡ »ê¸ð°¡ dzÁø¿¡ °É¸®¸é ÀÌ Ç³Áø ¹ÙÀÌ·¯½º´Â ŹÝÀ» ÅëÇØ¼ žƿ¡°Ô Àü´ÞµÇ¾î¼ žÆÀÇ Ç³Áø°¨¿°À» ÀÏÀ¸Å²´Ù. ÀӽŠù 3°³¿ù µ¿¾È, ƯÈ÷ ÀӽŠù´Þ¿¡ žư¡ dzÁøÀÇ °¨¿°À» ¹ÞÀ¸¸é, ½Å»ý¾Æ¿¡¼ ¼±Ãµ±âÇü, Áï ´«¿¡¼ ÃÐÁ¡À» Á¤È®È÷ ¸ÂÃß¾îÁÖ´Â ·»ÁîÀÇ ¿ªÇÒÀ» ÇÏ´Â ¼öÁ¤Ã¼ÀÇ È¥Å¹(¹é³»Àå), ½ÉÀå±âÇü, ±Í¸Ó°Å¸® ¹× ½ÉÇÑ Áö´É¹Ú¾àÀ» µ¿¹ÝÇÏ´Â ¼ÒµÎÁõ µîÀÌ ¹ß»ýÇÏ´Â ¼ö°¡ ¸¹´Ù. |
||
| ¿µ¹® | carpal tunnel syndrome | ÇÑ±Û | ¼Õ¸ñ±¼ÁõÈıº |
|---|---|---|---|
| ¼³¸í | ¼Õ¸ñ¿¡´Â ¾ÆÈ© °³ÀÇ ÈûÁÙ°ú ÇÑ °³ÀÇ ½Å°æÀÌ Åë°úÇÏ´Â ±¼ÀÌ Àִµ¥ À̰÷À» ¼Õ¸ñ±¼À̶ó Çϰí, À̰÷À» Áö³ª´Â ½Å°æÀÌ ´¸®¸é »õ±ú¼Õ°¡¶ôÀ» Á¦¿ÜÇÑ ³× ¼Õ°¡¶ôÀÌ ¾ÆÇÁ°í Àú¸° Áõ»óÀÌ´Ù. À̰ÍÀ» ¼Õ¸ñ±¼ÁõÈıºÀ̶ó ÇÑ´Ù. °Ë»ç ¹æ¹ýÀ¸·Î´Â ±ÙÀ° °Ë»ç¿Í ½Å°æÀü´Þ°Ë»ç°¡ ÀÖ´Ù. ½ÉÇÒ ¶§´Â ¾ÆÄ§À̳ª Àú³á¿¡ ¾ÆÆÄ¼ ÀáÀ» ±ú°í ¼Õ¸ñ»Ó¸¸ ¾Æ´Ï¶ó ¾î±ú±îÁö ¾ÆÇÁ´Ù. ¼Õ¸ñÀ» ±ÁÈ÷°í ÀÖÀ¸¸é ÅëÁõÀÌ ½ÉÇÏ´Ù. ¼Õ¸ñÀ» ¹Ýº¹ÀûÀ¸·Î »ç¿ëÇÏ´Â ¿îÀüÀÚ, °¡Á¤ÁÖºÎ, ¾Ç±â ¿¬ÁÖÀÚ, °øÀå¶óÀÎÀÇ ±Ù·ÎÀÚ, ÄÄÇ»ÅÍ »ç¿ëÀÚ, ¸ñ¼ö°¡ ÇØ´çµÈ´Ù. ¼Õ¹Ù´Ú»À°¡ ±úÁö°Å³ª ³Ñ¾îÁö¸é¼ ¼Õ¹Ù´ÚÀ¸·Î ¤¾úÀ» ¶§µµ ¹ß»ýÇÏ¸ç µå¹°°Ô Áøµ¿ÇÏ´Â °ø±¸¸¦ »ç¿ëÇØµµ ³ªÅ¸³ª±âµµ ÇÑ´Ù. ÀÓ»êºÎ, Åëdz, ·ù¸¶Æ¼½º °üÀý¿°, °©»ó»ù ±â´É ÀúÇÏÁõ, ´ç´¢º´ µîÀÌ ÀÖÀ» ¶§ ÀÌ·± Áõ»óÀÌ ¿Ã ¼ö ÀÖ´Ù. ¿©ÀÚ¿¡°Ô ´õ ¸¹°í ÁÖ·Î ÀÚÁÖ ¾²´Â ¼Õ¸ñÀÌ ÇØ´çµÈ´Ù. ½ÉÇÒ ¶§´Â ¼Õ¸ñ¿¡ ¶¥ÄḸÇÑ Å©±â·Î ºÎ¾î¿À¸¥´Ù. ´©¸£¸é ¾ÈÀ¸·Î ¾¦ µé¾î°¡±âµµ ÇÏ°í ´Ù½Ã ¿òÁ÷ÀÌ¸é Æ¢¾î³ª¿Â´Ù. ¼Õ¸ñ»À ¿©´ü °³ Áß¿¡ ¹Ý´Þ»À¶ó ºÒ¸®´Â ÀÛÀº»ÀÀÇ Àδ밡 ÀÌ¿ÏµÇ¾î »ý±ä´Ù. ÅëÁõÀ» °¨¼ÒÇÏ´Â Ä¡·á·Î ºÎ¸ñ, ¾óÀ½ÂòÁú, ÀÌ´¢Á¦, Ç×»ýÁ¦¸¦ »ç¿ëÇϱ⵵ Çϸç ÅëÁõÀÌ °è¼ÓµÇ¸é ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å È£¸£¸óÀ» ¼Õ¸ñºÎ¿¡ ÁÖ»çÇÏ¿© ÅëÁõÀ» ÁÙÀδÙ. ºÎÀÛ¿ëÀ¸·Î´Â Àç¹ß·üÀÌ ³ô´Ù. |
||
| ¿µ¹® | sudden infant death syndrome | ÇÑ±Û | ¿µ¾Æ±Þ»çÁõÈıº |
|---|---|---|---|
| ¼³¸í | ÇÑ »ì ÀÌÇÏÀÇ °Ç°ÇÑ ¾Æ±â°¡ ¾Æ¹«·± Á¶ÁüÀ̳ª ¿øÀÎ ¾øÀÌ °©Àڱ⠻ç¸ÁÇßÀ» °æ¿ì¿¡ ³»¸®´Â Áø´ÜÀÌ´Ù. ÀÌ ÁõÈıºÀº »ýÈÄ 1~4°³¿ù »çÀÌ¿¡ °¡Àå ¸¹ÀÌ ¹ß»ýÇϸç, ´ëºÎºÐ ¹ã 10½Ã¿¡¼ ¿ÀÀü 10½Ã »çÀÌ¿¡ ¹ß»ýÇÑ´Ù. Á¶»êÇϰųª ºÎ¸ð°¡ Èí¿¬ÀÚÀÏ °æ¿ì, 20¼¼ ÀÌÇÏ »ê¸ðÀÇ ÃÊ»ê, ÀÓ½ÅÀü °Ç°°ü¸®¿¡ ¼ÒȦÇÑ »ê¸ð¿¡°Ô¼ ÅÂ¾î³ ¿µ¾Æ¿¡°Ô¼ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ÀÌ ÁõÈıºÀ¸·Î »ç¸ÁÇÑ ¿µ¾ÆÀÇ ÇüÁ¦ÀÏ °æ¿ì ÀϹÝÀûÀÎ ¿µ¾Æº¸´Ù °É¸± È®·üÀÌ ³ôÀº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. |
||
| ¿µ¹® | severe acute respiratory syndrome(SARS) | ÇÑ±Û | ÁßÁõ±Þ¼ºÈ£ÈíÁõÈıº |
|---|---|---|---|
| ¼³¸í | Áß±¹ ±¤µ¿ Áö¿ª¿¡¼ °¡Àå ¸ÕÀú ¹ß»ýÇÑ Àü¿°¼ºÈ£Èí±âº´À¸·Î ¼¼°èº¸°Ç±â±¸(WHO)¿¡¼ ¡®ÁßÁõ±Þ¼ºÈ£ÈíÁõÈıº(SARS)'À¸·Î ¸í¸íÇß´Ù. ¼·¾¾ 38µµ ÀÌ»óÀÇ °í¿°ú ±âħ, È£Èí°ï¶õ, Àú»ê¼ÒÁõ, X¼±»óÀÇ Æó·ÅÁõ»ó Áß Çϳª ÀÌ»óÀÇ Áõ»óÀÌ ³ªÅ¸³ª¸ç, µÎÅë, ±ÙÀ°Åë, ½Ä¿åºÎÁø, ÇǷΰ¨, ¹ßÁø, ¼³»ç¸¦ µ¿¹ÝÇÒ ¼ö ÀÖ´Ù. Ãʱâ Áõ»óÀº °¨±â¿Í ºñ½ÁÇÏÁö¸¸ Æó·ÅÀ¸·Î ¹ßÀüÇϸé Ä¡¸íÀûÀÏ ¼ö ÀÖ´Ù. ÇöÀç ¹àÇôÁø °¨¿°°æ·Î´Â ȯÀÚ°¡ Àçä±â³ª ±âħÇÒ ¶§ ³»»Õ´Â ħ¹æ¿ïÀ̰í, À̰ÍÀÌ ´Ù¸¥ »ç¶÷ÀÇ È£Èí±â·Î µé¾î°¥ ¶§ Àü¿°µÈ´Ù. ħ¹æ¿ïÀÌ Àü´ÞµÇ´Â °Å¸®´Â º¸Åë 1m·Î º¸°í ÀÖ´Ù. °ø±â¸¦ ÅëÇØ Àü¿°ÀÌ °¡´ÉÇÏ´Ù´Â ÁÖÀåÀÌ Á¦±âµÆÁö¸¸ ¾ÆÁ÷ È®ÀεÇÁö ¾Ê¾Ò´Ù. ¿øÀαÕÀº º¯Á¾ Äڷγª¹ÙÀÌ·¯½º·Î ¹àÇôÁ³´Ù. |
||
| ¿µ¹® | syndrome | ÇÑ±Û | ÁõÈıº |
|---|---|---|---|
| ¼³¸í | Áõ»óÀÇ ÁýÇÕ. ¾î¶² Áúº´ÀÇ Â¡ÈÄÀÇ ÃÑÇÕÀ» ¸»ÇÑ´Ù. ´ë°³ ±× ¿øÀÎÀº ¾Ë ¼ö ¾øÀ¸³ª, Áõ»óÀÌ º¹ÇÕÀûÀ¸·Î ³ªÅ¸³ª°í ÀÌ¿¡ ´ëÇÑ Ä¡·á°¡ ÀÏÁ¤ÇÑ °æ¿ì ÇϳªÀÇ ÁõÈıºÀ¸·Î Ãë±ÞÇÑ´Ù. |
||
| WDHA Syndrome | Watery Diarrhea, Hypokalemia, Achlorhydria Syndrome = Pancreatic Cholera (Syndrome)<... |
|---|---|
| HS | Haber syndrome; half strength; hamstring; hand surgery; Hartmann solution; head sling; healthy subje... |
| KS | Kallmann syndrome; Kaposi sarcoma; Kartagener syndrome; Kawasaki syndrome; keratan sulfate; ketoster... |
| RS | radioscaphoid; random sample; rating schedule; Raynaud syndrome; recipient's serum; rectal sinus; re... |
| ABP | actin-binding protein; ambulatory blood pressure; American Board of Pedodontics; American Board of P... |
| blood protein electrophoresis | Electrophoresis applied to blood proteins. (12 Dec 1998) |
|---|---|
| bone Gla protein | <protein> Polypeptide of 50 residues formed from a 76-77 amino acid precursor and found in the extracellular matrix of bone. Binds hydroxyapatite. Has limited homology of its leader sequence with that of other Vitamin K dependent proteins such as prothrombin, Factors IX and X and Protein C. (18 Nov 1997) |
| bone morphogenetic protein | <protein> Activity derived from bone that induces the formation of cartilage and bone in vivo. Seven bone morphogenetic proteins have been described, BMP 1 being the only one not in the TGF beta superfamily. BMP 3 was formerly called osteogenin. Acronym: BMP (18 Nov 1997) |
| BRCA1 protein | Phosphoprotein encoded by the BRCA1 gene (genes, BRCA1). It has limited sequence similarity with known proteins. In normal cells the BRCA1 protein is localised in the nucleus, whereas in the majority of breast cancer cell lines and in malignant pleural effusions from breast cancer patients, it is localised mainly in the cytoplasm. (science 1995;270(5237):713,789-91) (12 Dec 1998) |
| byr1 protein kinase | <enzyme> Has been sequenced; from schizosaccharomyces pombe; antibody to this enzyme also reacts with s. Cerevisiae protein kinase ste7 and with a map kinase kinase from cos cells Registry number: EC 2.7.1.- (26 Jun 1999) |
| calcium-binding protein | <biochemistry> There are two main groups of calcium binding proteins, those that are similar to calmodulin and are called EF hand proteins and those that bind calcium and phospholipid (e.g. Lipocortin) and that have been grouped under the generic name of annexins. Many other proteins will bind calcium, although the binding site usually has considerable homology with the calcium-binding domains of calmodulin. They can act as transport proteins, regulator proteins or activator proteins. There is also a vitamin D-dependent variant which is a protein that plays a fundamental role in the vitamin d mediated transport of calcium in reptiles, amphibians, birds and mammals. It is found in the intestine, kidneys, egg shell gland, brain, and possibly other organs. Its molecular weight is species dependent. (12 May 2002) |
| calcium-calmodulin dependent protein kinase | <enzyme> A calmodulin-dependent enzyme that catalyses the phosphorylation of proteins. This enzyme is also sometimes dependent on calcium. A wide range of proteins can act as acceptor, including vimentin, synapsin, glycogen synthase, myosin light chains, and the microtubule-associated proteins. Registry number: EC 2.7.10.- (12 Dec 1998) |
| calcium-dependent protein kinase | <enzyme> Mw 51,000; requires ca; not stimulated by calmodulin, phospholipids or diacylglycerol; phosphorylates casein and histones forming primarily phosphoserine and phosphothreonine, respectively Registry number: EC 2.7.1.- Synonym: paramecium ca-dependent protein kinase (26 Jun 1999) |
| calcium dependent regulator protein | <protein> (CDRP) Early name for calmodulin. (18 Nov 1997) |
| calmodulin-dependent protein kinase IV kinase | <enzyme> Phosphorylates and activates cam-kinase iv; from brain Registry number: EC 2.7.10.- Synonym: cam-kinase iv kinase (26 Jun 1999) |
| cAMP receptor protein | catabolite (gene) activator protein |
| cap binding protein | <molecular biology, protein> Protein (24 kD) with affinity for cap structure at 5' end of mRNA that probably assists, together with other initiation factors, in binding the mRNA to the 40S ribosomal subunit. Translation of mRNA in vitro is faster if it has a cap binding protein. (18 Nov 1997) |
| p150 protein kinase | <enzyme> Mw 150 kD; forms a cellular complex with phosphatidylinositol 3-kinase; a homolog of vps15 protein kinase; amino acid sequence given in first source Registry number: EC 2.7.1.- (26 Jun 1999) |
| p21(ras) farnesyl-protein transferase | <enzyme> Transfers the farnesyl moiety from farnesyl pyrophosphate to a cysteine in p21(ras) proteins; composed of an alpha and a beta subunit Registry number: EC 2.5.1.- Synonym: farnesyl-protein transferase p21(ras), ras p21 farnesyl-protein transferase, protein-cysteine farnesyltransferase, pc farnesyltransferase, protein farnesyltransferase, p21(ras) farnesyltransferase, farnesyl-protein transferase-alpha, farnesyl-protein transferase-beta, ft alpha, ft beta, caax farnesyltransferase, ftase enzyme (26 Jun 1999) |
| P400 protein | <protein> Inositol 1,4, 5 triphosphate receptor (InsP3 R). Key protein to understanding mechanisms of InsP3 mediated Ca mobilisation. Originally found as a cerebellar glycoprotein of 250 kD and subsequently shown to be identical to the InsP3 receptor protein. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|